Page last updated: 2024-11-06

prednisolone and Hypopigmentation

prednisolone has been researched along with Hypopigmentation in 2 studies

Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.

Hypopigmentation: A condition caused by a deficiency or a loss of melanin pigmentation in the epidermis, also known as hypomelanosis. Hypopigmentation can be localized or generalized, and may result from genetic defects, trauma, inflammation, or infections.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bae, JM1
Kwon, HS1
Lee, JH1
Kim, GM1
Holder, GE1
Robson, AG1
Pavesio, C1
Graham, EM1

Other Studies

2 other studies available for prednisolone and Hypopigmentation

ArticleYear
Repigmentation of poliosis in a patient with segmental vitiligo.
    Journal of the American Academy of Dermatology, 2016, Volume: 75, Issue:1

    Topics: Administration, Oral; Administration, Topical; Adult; Combined Modality Therapy; Eyebrows; Eyelids;

2016
Electrophysiological characterisation and monitoring in the management of birdshot chorioretinopathy.
    The British journal of ophthalmology, 2005, Volume: 89, Issue:6

    Topics: Adult; Chorioretinitis; Drug Monitoring; Drug Therapy, Combination; Electrooculography; Electroretin

2005